Application of compound AN-329 for inhibiting releasing and diffusing of hantavirus
A technology of AN-329 and hantavirus, applied in antiviral agents, medical preparations containing active ingredients, organic active ingredients, etc., can solve the problems of severe symptoms, high mortality, and lack of specific and effective therapeutic drugs
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0017] The present invention will be described in detail below in conjunction with the accompanying drawings and specific embodiments.
[0018] 1. Screening of key epitope sequences affecting HTNV-related Gn cytoplasmic tail
[0019] (1) Forecast
[0020] First, use bioinformatics technology to design small molecules that can hinder the interaction between Gn and ESCRT, and select 45 small molecule compounds whose structures can enter the active center of ESCRT from the small molecule compound library.
[0021] (2) Screening
[0022] A549 cells were digested and passaged to 6-well cell culture plates. When the cell density reached 60%, HTNV was infected according to MOI=1. 6 hours after infection, cell culture supernatant was added according to different compound concentrations, mixed evenly, and placed in CO at 37°C. 2 The cells were cultured in the incubator for 24 hours, and the A549 cells were digested and passaged to a new 96-well plate on the same day. After 24 hours ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com